We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New DNA Microarray System

By Biotechdaily staff writers
Posted on 10 Oct 2002
A new DNA microarray system combines ease of operation, a hybridization incubator that permits highly reproducible hybridization reactions ten times faster than other methods, and an image acquisition system. The system was exhibited at the annual meeting of the Japanese Cancer Society in Tokyo (Japan).

Called FD10, the microarray is based on the PamChip developed by PamGene International B.V. (S-Hertogenbosch, The Netherlands). The FD10 was jointly developed by PamGene and Olympus Optical Co. (Tokyo, Japan) and is being marketed by Olympus. The target market comprises universities and other academic research institutions, pharmacuetical firms, and food manufacturers.

"Combining the strengths of our PamChip--robustness, speed, and kinetic readout—with the ease of use and sensitivity of the FD10 is an excellent starting point for a successful entry in the microarray market,” said Tim Kievits, CEO of PamGene. The company was formed in 2001, with the objective of becoming a biodiscovery company for pharmaceutical research and development.




Related Links:
PamGene
Olympus Optical

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Automated Clinical Chemistry Analyzer
Envoy 500+
Automatic CLIA Analyzer
Shine i6000

Latest BioResearch News

Genetic Study Links Inherited Blindness to Gene Tied to Rare Metabolic Disorder
10 Oct 2002  |   BioResearch

Population-Scale Proteomics Study Identifies New Genetic-Protein Links
10 Oct 2002  |   BioResearch

Circulating Tumor DNA Helps Identify Targets for Personalized Immunotherapy
10 Oct 2002  |   BioResearch